Cherokee Insurance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.91M Hold
30,600
– – 0.72% 45
2026
Q2
$1.76M Hold
30,600
– – 0.68% 48
2026
Q1
$1.86M Hold
30,600
– – 0.7% 42
2025
Q4
$1.65M Hold
30,600
– – 0.67% 44
2025
Q3
$1.38M Hold
30,600
– – 0.59% 47
2025
Q2
$1.42M Hold
30,600
– – 0.62% 45
2025
Q1
$1.87M Hold
30,600
– – 0.82% 37
2024
Q4
$1.73M Buy
+30,600
New +$1.71M 0.78% 38

Other funds holding BMY

Cherokee Insurance's BMY Position: Q3 2026 in Review

Cherokee Insurance held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 30,600 shares worth $1.91M. The position accounts for 0.72% of the portfolio, ranked #45.

Cherokee Insurance first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Cherokee Insurance held 30,600 shares of Bristol-Myers Squibb worth $1.91M as of Q3 2026.
  • Cherokee Insurance left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.72% of Cherokee Insurance's portfolio in Q3 2026, its #45 holding.
  • Cherokee Insurance first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Cherokee Insurance's 13F filing for Q3 2026, filed 5 Nov 2026.